sec filing
DS
NASDAQ · DSGN
Design Therapeutics, Inc.
Healthcare · Biotechnology
$12.51
Up+$0.28 (+2.29%)
Updated Sep 17, 2026, 3:13 AM
SID Score
4.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 526.89M
- P/E ratio
- -8.28
- Dividend yield
- 0.00%
- 52-week range
- $9.69 – $17.25
- Volume
- 985.14K
- Avg. volume
- 297.9K
Price performance
DSGN price history
1M range · 20 trading sessions · Daily adjusted prices
DSGN closed at $12.51 after 20 trading sessions, down 21.55% for the selected period.
- Last close
- $12.51
- Period change
- -21.55%
- Period low
- $12.23
- Period high
- $15.94
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $12.34 | $12.86 | $12.22 | $12.505 | 985.14K |
| Sep 15, 2026 | $13.47 | $13.52 | $12.16 | $12.225 | 1.28M |
| Sep 14, 2026 | $14.71 | $14.76 | $13.43 | $13.52 | 1.26M |
| Sep 11, 2026 | $14.99 | $15.14 | $14.43 | $14.63 | 715.24K |
| Sep 10, 2026 | $14.81 | $15.00 | $14.508 | $14.80 | 653K |
| Sep 9, 2026 | $15.12 | $15.49 | $14.87 | $15.02 | 821.14K |
| Sep 8, 2026 | $15.00 | $15.39 | $14.71 | $15.23 | 775.06K |
| Sep 4, 2026 | $14.96 | $15.35 | $14.96 | $15.14 | 256.62K |
| Sep 3, 2026 | $15.49 | $15.49 | $14.83 | $15.03 | 376.17K |
| Sep 2, 2026 | $15.25 | $15.75 | $15.17 | $15.53 | 1M |
| Sep 1, 2026 | $14.95 | $15.22 | $14.64 | $15.14 | 476.96K |
| Aug 31, 2026 | $15.00 | $15.21 | $14.38 | $15.09 | 704.39K |
| Aug 28, 2026 | $15.12 | $15.36 | $14.80 | $15.11 | 820.76K |
| Aug 27, 2026 | $15.58 | $15.79 | $15.20 | $15.25 | 389.23K |
| Aug 26, 2026 | $15.60 | $15.83 | $15.295 | $15.59 | 718.73K |
| Aug 25, 2026 | $15.44 | $15.96 | $15.27 | $15.68 | 608.11K |
| Aug 24, 2026 | $14.91 | $15.47 | $14.64 | $15.23 | 408.65K |
| Aug 21, 2026 | $15.66 | $15.83 | $14.975 | $14.99 | 552.14K |
| Aug 20, 2026 | $15.69 | $15.83 | $15.31 | $15.56 | 511.05K |
| Aug 19, 2026 | $15.50 | $16.12 | $15.30 | $15.94 | 706.35K |
Latest DSGN news
The latest Smart Investors Daily articles mentioning DSGN.
Stock researchResearch & News · SEC Filings
Loading stock research…

